Chemomab Therapeutics Ltd. Current Income Tax Expense (Benefit)
Chemomab Therapeutics Ltd. (CMMB) reported Current Income Tax Expense (Benefit) of $306.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-17.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2020-03-17
- Chemomab Therapeutics Ltd. current income tax expense (benefit) for fiscal 2018 was $306.00K.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2018-12-31 | $306.00K 10-K · filed 2020-03-17 |